ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,090Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 5176

$2.11M Total Retail Price of All Prescriptions

Rank: 47 out of 5176

672 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 672 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 26,948 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 1,091 1,069 1 8
NEXIUM 916 854 2 16
AMLODIPINE BESYLATE 820 798 3 2
METOPROLOL TARTRATE 726 708 4 6
SIMVASTATIN 648 606 5 1
METOPROLOL SUCCINATE 557 519 6 11
PLAVIX 545 535 7 29
NAMENDA 525 525 8 47
ISOSORBIDE MONONITRATE ER 492 489 9 44
SYNTHROID 403 403 10 33
TRAZODONE HCL 397 380 11 71
CRESTOR 388 375 12 15
CLOTRIMAZOLE-BETAMETHASONE 382 363 13 94
CARVEDILOL 368 364 14 24
ZOLPIDEM TARTRATE 341 325 15 17
CLOPIDOGREL 340 331 16 26
LIDODERM 323 310 17 59
VOLTAREN 313 310 18 97
POTASSIUM CHLORIDE 306 306 19 34
OMEPRAZOLE 301 294 20 3
RAMIPRIL 297 289 21 50
SILVER SULFADIAZINE 296 273 22 207
TAMSULOSIN HCL 292 292 23 20
QUETIAPINE FUMARATE 292 282 23 75
GABAPENTIN 291 268 25 21
ATORVASTATIN CALCIUM 284 271 26 9
JANUVIA 283 257 27 25
ESCITALOPRAM OXALATE 278 277 28 89
DONEPEZIL HCL 277 277 29 28
LOSARTAN POTASSIUM 265 258 30 14
DIOVAN 259 259 31 19
SEROQUEL 258 251 32 166
MECLIZINE HCL 248 248 33 81
LIPITOR 234 223 34 51
NITROGLYCERIN PATCH 229 229 35 149
AZITHROMYCIN 224 212 36 42
METFORMIN HCL 224 202 36 7
LEVOTHYROXINE SODIUM 214 200 38 4
LISINOPRIL 214 214 38 5
DIGOXIN 214 202 38 56
LEVOFLOXACIN 212 199 41 109
LOVAZA 205 186 42 43
HYDRALAZINE HCL 204 197 43 73
SOLARAZE 196 183 44 157
TRAMADOL HCL-ACETAMINOPHEN 194 171 45 116
ENALAPRIL MALEATE 190 172 46 22
BENICAR 179 172 47 100
DIOVAN HCT 177 177 48 39
PROCTOZONE-HC 175 175 49 171
SERTRALINE HCL 174 171 50 30
RANEXA 166 152 51 167
BYSTOLIC 166 151 51 96
COUMADIN 165 165 53 112
WARFARIN SODIUM 163 151 54 13
CREON 160 160 55 111
ADVAIR DISKUS 158 144 56 32
CLONIDINE HCL 150 150 57 79
GLIPIZIDE XL 140 140 58 83
SINGULAIR 139 137 59 62
SPIRONOLACTONE 138 126 60 88
DETROL LA 133 125 61 249
CYMBALTA 132 122 62 90
ALCOHOL SWABS 132 132 62 115
LEVETIRACETAM 129 129 64 92
GLIMEPIRIDE 128 121 65 37
LACTULOSE 128 127 65 87
TRAMADOL HCL 126 126 67 40
LEXAPRO 124 124 68 193
FINASTERIDE 124 124 68 69
POLYETHYLENE GLYCOL 3350 110 110 70 74
RANITIDINE HCL 107 105 71 36
MELOXICAM 105 103 72 53
MIRTAZAPINE 104 104 73 45
LIDOCAINE 104 104 73 179
LANTUS 104 87 73 66
GLIPIZIDE ER 100 84 76 117
HYDROCHLOROTHIAZIDE 100 98 76 10
NASONEX 100 100 76 178
AMMONIUM LACTATE 95 95 79 91
CLOTRIMAZOLE 91 88 80 296
LUNESTA 90 82 81 242
FAMOTIDINE 89 89 82 58
ATENOLOL 85 85 83 12
CARBIDOPA-LEVODOPA 84 81 84 98
CELEBREX 82 79 85 80
CITALOPRAM HBR 81 66 86 31
LOSARTAN-HYDROCHLOROTHIAZIDE 81 81 86 35
SSD 80 75 88 216
VIIBRYD 78 77 89 537
ACETAMINOPHEN-CODEINE 76 76 S3 90 127
ALLOPURINOL 76 76 90 41
PROAIR HFA 74 74 92 60
AZOR 73 72 93 194
MICARDIS 73 69 93 154
SINGLE USE SWAB 73 67 93 108
CILOSTAZOL 73 73 93 206
LANSOPRAZOLE 72 72 97 113
HYDROCORTISONE 71 71 98 265
TEKTURNA 70 70 99 255
ONGLYZA 69 69 100 153
PRANDIN 69 56 100 150
FLUTICASONE PROPIONATE 67 63 102 38
BUMETANIDE 67 61 102 209
PRAVASTATIN SODIUM 67 67 102 23
DICYCLOMINE HCL 66 64 105 224
GLYBURIDE 66 51 R 105 67
DOXAZOSIN MESYLATE 66 66 105 103
PRADAXA 66 66 105 192
LACLOTION 63 63 109 299
DEXILANT 62 56 110 118
AVODART 62 62 110 107
VESICARE 58 58 112 210
INSULIN SYRINGE 58 51 112 137
AGGRENOX 56 56 114 235
EXELON 56 56 114 162
MUPIROCIN 55 55 116 182
PAROXETINE HCL 55 55 116 93
FENTANYL 51 51 S2 118 172
ZETIA 50 34 119 68
GLIPIZIDE 50 48 119 63
PREDNISONE 50 50 119 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.